# FDA Inspection 1309164 - Cantor BioConnect, Inc. - March 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/606f4ba3-5651-413a-b5b8-df5cceefc700
Source feed: FDA_Inspections

> FDA Inspection 1309164 for Cantor BioConnect, Inc. on March 24, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309164
- Company Name: Cantor BioConnect, Inc.
- Inspection Date: 2026-03-24
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1200803 - 2023-03-22](https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/647c9f97-73c9-4f91-8247-8f680d3c99f6)
- [FDA Inspection 1200803 - 2023-03-22](https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/9de06b39-78c0-472c-a6ee-526e4a7e53f0)

Company: https://www.keypedia.com/companies/cantor-bioconnect-inc/981435e7-15fc-4730-bb5e-ceb13c11f367

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b